Boehringer Ingelheim BioXcellence™ – Shanghai, China

Boehringer Ingelheim has made its strategic move to become a leader for contract development and manufacturing of monoclonal antibodies and recombinant proteins in China. Since 2014, Boehringer Ingelheim Biopharmaceuticals China has been running its production lines at 100L and 500L scales for GMP clinical material supply at BioLab, Shanghai. From Q1/2017 onwards, a larger GMP facility at 2,000L manufacturing scale - Oasis -  for clinical and commercial supply will be in operation. Both BioLab and Oasis are based on disposable technology.
Read more


What Shanghai can offer you:

  • Flexible, fully disposable GMP facility for clinical and early commercial supply up to 2,000L
  • Globally established disposable concept enabling smooth transfers to all and between different Boehringer Ingelheim sites
  • Upstream and downstream process development
  • Process transfer – all phases of clinical and commercial products
  • Clinical and commercial scale manufacturing
  • Project uptake at every step in project development
  • State-of-the-art Fill & Finish capabilities
  • And more ...

See below for our latest news about Boehringer Ingelheim Biopharmaceuticals in China:


Boehringer Ingelheim Biopharmaceuticals in China (whitepaper)

Biopharmaceutical contract manufacturing at Boehringer Ingelheim Shanghai

Contact Us

Boehringer Ingelheim BioXcellence - Contact Us

Do you have any inquiries, questions or comments? Please get in touch with us.